Metastatic Cholangiocarcinoma
Oncology·MeSH: Cholangiocarcinoma
Prevalence
2.5 / 100K
Incidence
1.3 / 100K/yr
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| Entinostat | Syndax Pharmaceuticals Inc (SNDX) |
Frequently asked questions
How many drugs are in development for Metastatic Cholangiocarcinoma?
BioSniper tracks 1 drug in development for Metastatic Cholangiocarcinoma across 1 company.
How many clinical trials target Metastatic Cholangiocarcinoma?
There are 3 clinical trials targeting Metastatic Cholangiocarcinoma tracked by BioSniper.
What is the prevalence of Metastatic Cholangiocarcinoma?
The estimated prevalence of Metastatic Cholangiocarcinoma is approximately 2.5 per 100,000 population.
Deep-dive into Metastatic Cholangiocarcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis